amifostine anhydrous has been researched along with d-alpha tocopherol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Srinivasan, V; Weiss, JF | 1 |
| Bubrick, MP; Carroll, MP; Feeney, DA; Johnston, GR; Roberts, JC; Schlafmann, SE; West, MA; Zera, RT | 1 |
| Kumar, S; Srinivasan, V; Weiss, JF | 1 |
| Anzai, K; Miura, Y; Ozawa, T; Ueda, J | 1 |
| Błasiak, J; Gloc, E; Majsterek, I; Młynarski, W; Skórski, T; Stolarska, M; Woźniak, K | 1 |
| Galanski, M; Jakupec, MA; Keppler, BK | 1 |
| Albers, J; Cavaletti, G; Chaudhry, V; Donehower, R | 1 |
| Karabay, G; Kıray, S; Kuscu, E; Onalan, G; Zeyneloglu, H | 1 |
| Fatanmi, OO; Newman, VL; Romaine, PL; Seed, TM; Singh, VK; Wise, SY | 1 |
| Depeš, D; Falk, M; Hofer, M; Hoferová, Z | 1 |
| Altun, GD; Ergulen, A; Muratli, A; Serim, BD; Torun, N | 1 |
| Anothaisintawee, T; Auttara-Atthakorn, A; Reutrakul, S; Sriphrapradang, C; Sungmala, J | 1 |
5 review(s) available for amifostine anhydrous and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The effect of cytoprotective agents in platinum anticancer therapy.
Topics: Amifostine; Antineoplastic Agents; Cell Survival; Glutathione; Humans; Mesna; Neoplasms; Platinum Compounds; Protective Agents; Thioctic Acid; Vitamin E | 2004 |
Interventions for preventing neuropathy caused by cisplatin and related compounds.
Topics: Adrenocorticotropic Hormone; Amifostine; Antineoplastic Agents; Cisplatin; Ditiocarb; Glutathione; Humans; Neuroprotective Agents; Peptide Fragments; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Vitamin E | 2007 |
Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review.
Topics: Acute Radiation Syndrome; Amifostine; Animals; Dinoprostone; Drug Administration Schedule; Drug Combinations; Drug Synergism; Granulocyte Colony-Stimulating Factor; Humans; Metformin; Misoprostol; Radiation Injuries, Experimental; Radiation-Protective Agents; Vitamin E | 2017 |
Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials.
Topics: Adenocarcinoma; Amifostine; Bethanechol; Humans; Iodine Radioisotopes; Pilocarpine; Randomized Controlled Trials as Topic; Salivary Glands; Selenium; Thyroid Neoplasms; Vitamin E | 2022 |
8 other study(ies) available for amifostine anhydrous and d-alpha tocopherol
| Article | Year |
|---|---|
Radioprotection by vitamin E: injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice.
Topics: Amifostine; Animals; Injections, Subcutaneous; Male; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents; Survival Rate; Vitamin E | 1992 |
Efficacy of radioprotective agents in preventing small and large bowel radiation injury.
Topics: Adenosine Triphosphate; Amifostine; Animals; Cysteine; Drug Therapy, Combination; Glutamine; Intestine, Large; Intestine, Small; Magnesium Chloride; Male; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines; Vitamin E | 1995 |
Radioprotection by misoprostol (PGE1 methyl analog) in combination with vitamin E, selenomethionine and WR-3689794.
Topics: Amifostine; Animals; Confidence Intervals; Drug Synergism; Gamma Rays; Male; Mice; Mice, Inbred Strains; Misoprostol; Pseudomonas Infections; Radiation-Protective Agents; Selenomethionine; Survival Rate; Vitamin E | 1997 |
Novel approach to in vivo screening for radioprotective activity in whole mice: in vivo electron spin resonance study probing the redox reaction of nitroxyl.
Topics: Amifostine; Animals; Ascorbic Acid; Chromans; Cimetidine; Cyclic N-Oxides; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Interleukin-1; Mice; Nitrogen Oxides; Oxidation-Reduction; Oxidative Stress; Pyrrolidines; Radiation-Protective Agents; Recombinant Proteins; Serotonin; Spin Labels; Stem Cell Factor; Vitamin E; Whole-Body Irradiation | 2000 |
Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine.
Topics: Adult; Amifostine; Animals; Antibiotics, Antineoplastic; Antioxidants; Ascorbic Acid; Cell Line, Transformed; Cell Survival; Comet Assay; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Endodeoxyribonucleases; Humans; Idarubicin; Lymphocytes; Male; Mice; Mutagens; Tumor Cells, Cultured; Vitamin E; Vitamins | 2002 |
Antioxidant prophylaxis for cellular injury in ovarian surface epithelium resulting from CO₂ pneumoperitoneum in a laparoscopic rat model.
Topics: Acetylcysteine; Amifostine; Animals; Antioxidants; Carbon Dioxide; Epithelium; Female; Free Radical Scavengers; Laparoscopy; Ovary; Oxidative Stress; Pneumoperitoneum, Artificial; Preoperative Care; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Vitamin E | 2011 |
THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.
Topics: Amifostine; Animals; Chromans; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Male; Mice; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Survival Rate; Treatment Outcome; Vitamin E; Whole-Body Irradiation | 2016 |
Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment.
Topics: Amifostine; Animals; Carcinoma, Papillary; Carnitine; Guinea Pigs; Injections, Intramuscular; Iodine Radioisotopes; Radiation Injuries, Experimental; Radiation Protection; Radiation-Protective Agents; Salivary Glands; Thyroid Neoplasms; Vitamin E | 2019 |